A drug commonly used to shrink enlarged prostate glands also increases the accuracy of the test used to detect aggressive forms of prostate cancer, Washington University researchers have found. Dr.

Prostate cancer is one of the most frequently diagnosed cancers in men yet is often highly treatable when detected early. It originates in the prostate gland, located between the bladder and the penis ...

While many people are familiar with mammograms and smear tests, prostate screening is talked about far less.To shed light on this important subject ahead of Prostate Cancer Awareness Month in March, ...

The Prostate Cancer Foundation (PCF) today announced a $10 million unrestricted gift from an anonymous donor to launch a TACTICAL (Therapy ACceleration To Intercept CAncer Lethality) Award, which will ...

There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...

Scientists have identified a novel two-pronged treatment method, offering significant potential for patients battling advanced prostate cancer. Experts at The Institute of Cancer Research, London, ...

If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...

AI is changing how cancer care decisions are made, empowering patients and doctors to make more personalized choices. For ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.

As men age, various health concerns become more prevalent, particularly those related to prostate health. One of the most common issues faced by older men is an enlarged prostate, which can lead to ...

If you're facing a prostate cancer diagnosis, this guide to best dietary practices will help simplify your shopping list Getty What you eat can affect your prostate health, for better or worse.

CHICAGO (Reuters) - Prostate cancer screening is not likely to benefit men over age 75 and is not recommended for them while more evidence is needed to determine whether younger men benefit from early ...